ES465059A1 - Production of specific immune nucleic acids cell dialysates and antibodies - Google Patents

Production of specific immune nucleic acids cell dialysates and antibodies

Info

Publication number
ES465059A1
ES465059A1 ES465059A ES465059A ES465059A1 ES 465059 A1 ES465059 A1 ES 465059A1 ES 465059 A ES465059 A ES 465059A ES 465059 A ES465059 A ES 465059A ES 465059 A1 ES465059 A1 ES 465059A1
Authority
ES
Spain
Prior art keywords
nucleic acids
specific
specific immune
dialysates
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES465059A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Institute of Differentiation Ltd
Original Assignee
International Institute of Differentiation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Institute of Differentiation Ltd filed Critical International Institute of Differentiation Ltd
Publication of ES465059A1 publication Critical patent/ES465059A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Gamma-globulins and immune nucleic acids, both specific to a given antigen, are produced by culturing in vitro an inducible cell line in the presence of specific immune nucleic acids or specific immune dialysates obtained either from human or animal donor lymphoid cells sensitized to said specific antigen or from cells of a previously induced cell line sensitized to said specific antigen, or in the presence of the liquid phase of a culture of a previously induced cell line sensitized to said specific antigen and extracting gamma-globulins from the liquid phase of the thus induced cell culture and/or extracting the immune nucleic acids from the cells so cultured. Specific immune dialysates may also be produced by a similar process.
ES465059A 1976-12-16 1977-12-14 Production of specific immune nucleic acids cell dialysates and antibodies Expired ES465059A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB52674/76A GB1594097A (en) 1976-12-16 1976-12-16 Production of specific immune nucleic acids cell dialysates and antibodies

Publications (1)

Publication Number Publication Date
ES465059A1 true ES465059A1 (en) 1978-09-01

Family

ID=10464835

Family Applications (1)

Application Number Title Priority Date Filing Date
ES465059A Expired ES465059A1 (en) 1976-12-16 1977-12-14 Production of specific immune nucleic acids cell dialysates and antibodies

Country Status (14)

Country Link
US (1) US4224404A (en)
JP (1) JPS5375321A (en)
AU (1) AU3151977A (en)
BE (1) BE861857A (en)
CA (1) CA1110988A (en)
DK (1) DK557477A (en)
ES (1) ES465059A1 (en)
FI (1) FI773784A (en)
FR (1) FR2374330A1 (en)
GB (1) GB1594097A (en)
IE (1) IE46215B1 (en)
LU (1) LU78690A1 (en)
NL (1) NL7713832A (en)
NO (1) NO774311L (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364347D1 (en) * 1982-04-09 1986-08-07 Fujirebio Kk Anti immune complex antibody and preparation thereof
DE3245665A1 (en) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR PRODUCING PERMANENT ANIMAL AND HUMAN CELL LINES AND THE USE THEREOF
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4851510A (en) * 1984-11-30 1989-07-25 Wadley Technologies, Inc. Monoclonal antibodies to novel melanoma-associated antigens
US5004681B1 (en) * 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US6867195B1 (en) * 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
DE69034078T2 (en) * 1989-03-21 2004-04-01 Vical, Inc., San Diego Expression of exogenous polynucleotide sequences in vertebrates
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) * 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
DE69031951T2 (en) * 1989-11-16 1998-08-13 Cornell Res Foundation Inc Transformation of animal skin cells with the help of particles
US6228844B1 (en) 1991-11-12 2001-05-08 Vical Incorporated Stimulating vascular growth by administration of DNA sequences encoding VEGF
US6706694B1 (en) 1990-03-21 2004-03-16 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
US20030186913A1 (en) * 1990-03-21 2003-10-02 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
NZ262582A (en) * 1993-01-26 1997-10-24 David B Weiner Compositions and methods for delivery of genetic material
US5981505A (en) * 1993-01-26 1999-11-09 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US20040087521A1 (en) * 1993-03-18 2004-05-06 Merck & Co., Inc. Nucleic acid pharmaceuticals-influenza matrix
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
US6348449B1 (en) 1993-09-21 2002-02-19 The Trustees Of The University Of Pennsylvania Methods of inducing mucosal immunity
IL112820A0 (en) * 1994-03-07 1995-05-26 Merck & Co Inc Coordinate in vivo gene expression
US6995008B1 (en) 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617545C2 (en) 1967-06-19 1983-11-03 Diether Prof. Dr. Bern Jachertz Use of informational ribonucleic acid as a vaccine
GB1443948A (en) 1972-10-20 1976-07-28 Piktor Ltd Production of immunological material

Also Published As

Publication number Publication date
NO774311L (en) 1978-06-19
FI773784A (en) 1978-06-17
GB1594097A (en) 1981-07-30
JPS5375321A (en) 1978-07-04
CA1110988A (en) 1981-10-20
NL7713832A (en) 1978-06-20
AU3151977A (en) 1979-06-21
FR2374330A1 (en) 1978-07-13
FR2374330B3 (en) 1981-02-06
DK557477A (en) 1978-06-17
LU78690A1 (en) 1979-02-02
US4224404A (en) 1980-09-23
IE46215L (en) 1978-06-16
IE46215B1 (en) 1983-04-06
BE861857A (en) 1978-06-14

Similar Documents

Publication Publication Date Title
ES465059A1 (en) Production of specific immune nucleic acids cell dialysates and antibodies
JPS5673029A (en) Production of antibody against hepatitis virus and cell system therefor
ATE2965T1 (en) CELL LINES, METHODS FOR THEIR PRODUCTION AND METHODS FOR PRODUCTION OF ANTIBODIES.
NL300020I2 (en) Production of virus antigens.
MY106561A (en) Method of making factor-dependent human b cell lines
NZ181201A (en) A culture bottle,method of preparation and method of culturing
ES480474A1 (en) A serological method for determining the presence of Neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen.
ES8106552A1 (en) Process for propagating human hepatitis A virus in in vitro cell culture.
ES8104405A1 (en) Influenza virus vaccines, process for preparing them and process for propagating influenza viruses.
PT72301B (en) Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens
NZ183731A (en) Process for culturing cells(microorganism and tissue culture) dependent on the relationship between cycle time and biomass efficiency ratio
IE44448L (en) Gonococcal pili.
GB1443948A (en) Production of immunological material
US4017361A (en) Process for obtaining continuous lines of tumoral cells in vitro
KR850006705A (en) Method for producing anti-tetanus antibody-producing human-human hybridoma
ES424506A1 (en) Process for reducing sticking of blood cells to glass in blood testing procedures
PT83368A (en) Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens
ES438723A1 (en) Method of cultivating single-cell food proteins by a fermentation process
GB1436323A (en) Cell and virus culture systems
JPS5254019A (en) Method of making biological preparations
ES405090A1 (en) Preparation of citric acid
KR890701631A (en) Human Monoclonal Antibodies Against Aspergillus
JPS5329991A (en) Production of vegetable cells in low concentration medium
SU1398393A1 (en) MUSMULUS MUSCULUS HYBRID CULTIVATED ANIMAL CELLS STRAIN USED TO OBTAIN MONOCLONAL ANTIBODIES TO MYOCOBTERIA OF TUBERCULOSIS
ES437426A1 (en) Procedure for the preparation of a substance with immune effect. (Machine-translation by Google Translate, not legally binding)